ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | +20.8% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | +9.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +29.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +21.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $14,000 | -26.3% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | -74.3% | 12,000 | -71.4% | 0.00% | -50.0% |
| Q1 2021 | $74,000 | -89.9% | 42,000 | -88.8% | 0.00% | -94.6% |
| Q4 2020 | $734,000 | -14.2% | 376,319 | +161.8% | 0.04% | -17.8% |
| Q2 2016 | $855,000 | -12.7% | 143,769 | +18.8% | 0.04% | -26.2% |
| Q1 2016 | $979,000 | -0.4% | 120,976 | -0.6% | 0.06% | -39.6% |
| Q4 2015 | $983,000 | -3.4% | 121,756 | 0.0% | 0.10% | +16.1% |
| Q3 2015 | $1,018,000 | -10.5% | 121,756 | -0.9% | 0.09% | +26.1% |
| Q2 2015 | $1,138,000 | -4.3% | 122,856 | +1.3% | 0.07% | -6.8% |
| Q1 2015 | $1,189,000 | – | 121,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |